INSMED Inc — Director's Dealing 2020

Feb 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2020-02-03

Reporting Person: Bonstein Sara (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-03	Stock Option (right to buy)	$28.88	A	91640	Acquired	2030-02-03	Common Stock (91640)	Direct

Footnotes

F1: In connection with the appointment of Ms. Bonstein as the Company's Chief Financial Officer, the Company granted Ms. Bonstein an option to purchase a total of 91,640 shares of the Company's common stock. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date.